Medical News

Functional Capacity Past Age 40 in Patients with Congenital...
J Am Heart Assoc.

Patients with VSDs demonstrate poorer exercise capacity than healthy peers. The difference between patients and...

25 Sep 2020

Transcatheter or Surgical Aortic Valve Implantation in Chron...
Clin Res Cardiol.

Chronic dialysis patients with AS undergoing TAVI or SAVR had the same 1-year mortality, although survival at 30...

24 Sep 2020

Glucose Variability and the Risks of Stroke, Myocardial Infa...
Cardiovasc Diabetol.

In diabetes, long-term glucose variability showed a dose–response relationship with the risk of stroke, MI, and all...

24 Sep 2020

Low-Density Lipoprotein Cholesterol and Adverse Cardiovascul...
J Am Coll Cardiol.

One in 2 patients had LDL-C measured within 6 months after PCI, and only 57% had LDL-C <70 mg/dl. Higher levels...

23 Sep 2020

Key Trials

TRANSITION: Impact of Sacubitril/valsartan on NT-proBNP in Hospitalized HFrEF Patients

This post hoc analysis of TRANSITION study demonstrated a rapid and significant reduction in NT-proBNP, and favourable outcomes in patients with...

Impact of Glucose-lowering Drugs or Strategies on CV Events in Individuals with or at Risk of T2DM

This updated systematic review and meta-analysis demonstrated that use of glucose lowering drugs or strategies reduced the risk of fatal and non-...

Role of Echocardiographic Biomarkers to Ascertain the Effect of Sacubitril–valsartan on Vascular Properties in Patients with HFrEF

Sacubitril-valsartan treatment was associated with improvement in indices of vascular compliance as ascertained by echocardiographic evaluation. The...

Anticoagulation Management Post-PEA in Patients with CTEPH: The Current Scenario

This is the largest study that provides a direct comparison of vitamin K antagonists and direct oral anticoagulants used for the management of...

Slide Library

Medical Management Strategy of CTEPH: Role of Riociguat

Riociguat, a stimulator of soluble guanylate cyclase, has been globally approved for the treatment of PAH and inoperable CTEPH and persistent/...

 
Email this page
Macitentan: 1st ERA Proven to Reduce Morbidity and Mortality in PAH

Macitentan is an orally active, potent, tissue targeting ERA that is indicated for the treatment of pulmonary arterial hypertension (PAH). It is the...

 
Email this page
Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is the presence of mean pulmonary artery pressure (mPAP) ≥ 25 mmHg following an episode of...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page

Our Publications

Telyse (Tenecteplase) Monograph

In the management of STEMI in India, pharmacoinvasive strategy involving thrombolytics is the preferred therapy in cases of delays in primary PCI....

Mexiletine FAQ Booklet

Mexiletine is a class 1B antiarrhythmic agent, which blocks the sodium channels and is indicated in suppression of ventricular arrhythmias. The...

Mexohar (Mexiletine) Monograph

About 5% of patients with cardiac arrhythmias or with heart failure are diagnosed with a ventricular tachycardia. Recurrent Ventricular Tachycardia...

Gutron (Midodrine hydrochloride) Monograph

Orthostatic Hypotension is common in elderly (>70 years of age) and can also occur secondary to neuropathy like in diabetes or central lesions...

Patient Education

Understanding Angioplasty

Angioplasty is a life-saving procedure to open up blocked or narrowed blood vessels. This document gives a brief idea about the procedure.

Understanding Obesity

This document explains what is obesity, what is the impact of obesity on overall health and what are the benefits of weight loss. 

Hypertension

Know more about the risk factors, associated ill-effects and tips for management of hypertension or high blood pressure. 

Poll

What percent of your patients who need oral anticoagulation, receive warfarin?
<20%
24% (5 votes)
20-40%
19% (4 votes)
40-50%
14% (3 votes)
50-70%
14% (3 votes)
70-80%
24% (5 votes)
Almost all
5% (1 vote)
Total votes: 21